The first Arrowhead Pharmaceuticals trade was made in Q2 2017. Since then Jim Simons bought shares nine more times and sold shares on thirteen occasions. The investor sold all their shares in Q4 2024 and doesn't own any shares in Arrowhead Pharmaceuticals anymore.